Clinical Research
The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. The department has several on-going studies, as well as ones that are open for enrollment. If you are interested in being contacted about future studies, please sign the Patient List Research Consent Form. Once completed, please return it at your next clinic appointment or by mail to the following:
Bonita Baker
Division of Pediatric Endocrinology and Diabetes
Stanford University School of Medicine
Room G-313 Medical Center
300 Pasteur Drive
Stanford, CA, USA 94305-5208
Subject Recruitment
The following studies are currently recruiting study subjects. Please click on the study title for more information.
Study Title |
Looking for... |
Relatives of people with type 1 diabetes. First degree blood relatives ages 1-45 and second degree relatives ages 1-20. If you wish to do remote screening through Quest |
|
Type 1 Diabetes TrialNet: Oral Insulin Study
|
Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study |
| Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study | |
| Type I Diabetes TrialNet Protocol TN-10, Anti-CD3 mAb (Teplizumab) for Prevention of Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus |
Relatives of people with type 1 diabetes. Start with the Pathway to Prevention Study |
| The T1D Exchange Type 1 Diabetes Network | Individuals with type 1 diabetes. |
| Below are studies we generally offer to potential subjects during a clinical visit | |
| TN LIFT (longterm followup) | Consent Assent Handbook |
| DKA Neurocognition | Consent Assent Handout |
| Aromatase Inhibitor Growth Study | Growth study for pubertal MALES older than 10 years. |
| Development of Algorithms for a Prototype Closed Loop Insulin Pump (Closed Loop 1) | Patients with type 1 diabetes ages 3-31 who were diagnosed within the past year and are currently using an insulin pump. |
| Sponsored multicenter depot lupron study | |
| Depot Lupron Study | Patients with newly diagnosed Central Precocious Puberty who have not started medical therapy. |
| General Use of a Glucose Sensor | Consent Assent |
| CLINICAL Pamidronate Therapy for Children | Consent |
| Data collection protocol | |
| This is an IRB approved protocol to allow Stanford to do some tests required of OUTSIDE protocols here at Stanford when appropriate. |
Please check back for study updates and the addition of new studies.
